Japan Looks To Build Domestic Capacity In New Modalities

New Govt Funding For CGT Production

Japan's cell and gene therapy support
Japan's METI has budgeted JPY38.3bn to support building domestic CDMOs for cell and gene therapy. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Japan

More from Advanced Technologies